( en | de | ru )

 

Disambiguation of "Weller, M"

Author of the publication

copydeleteadd this publication to your clipboard
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations

, , , , , , , , , , , and . Clin Cancer Res, 19 (18): 5146-5157 (September 2013)
DOI: 10.1158/1078-0432.CCR-13-0017

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

M G Weller

Karin Weller

Dieter Weller

Frank Weller

Christine Weller

 

Other publications of authors with the same name

Complementary therapy use in patients with glioma: an observational study, , , , , , , , , and 7 other author(s). Neurology, 75 (24): 2229–2235 (2010)Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy, , , , , , , , , and 6 other author(s). Int J Cancer, 134 (10): 2437-2447 (May 2014)Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling, , , , , , , , , and 18 other author(s). Int J Cancer, 135 (8): 1822-1831 (October 2014)ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma, , , , , , , , , and 9 other author(s). Acta Neuropathol, 129 (1): 133-146 (January 2015)A comprehensive analysis of vascular complications in 3,889 glioma patients from the German Glioma Network, , , , , , , , , and 1 other author(s). J Neurol, 260 (3): 847-855 (March 2013)Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells, , , , , , , and . J Neurochem, 122 (2): 444-455 (July 2012)Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma, , , , , , , , , and 4 other author(s). Genes Chromosomes Cancer, 53 (7): 589-605 (July 2014)Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations, , , , , , , , , and 46 other author(s). Acta Neuropathol, (March 2018)Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities, , , , , , , , , and 17 other author(s). Acta Neuropathol, 130 (3): 407-417 (September 2015)NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide, , , , , , , , , and 10 other author(s). J Clin Oncol, 27 (35): 5874-5880 (December 2009)